Publikationer av Ronald Sjöberg
Refereegranskade
Artiklar
[1]
L. Lourido et al., "Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis," Rheumatology, vol. 63, no. 11, s. 3106-3114, 2024.
[2]
A. Jernbom Falk et al., "Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19," Nature Communications, vol. 15, no. 1, 2024.
[3]
D. R. Dou et al., "Xist ribonucleoproteins promote female sex-biased autoimmunity," Cell, vol. 187, no. 3, s. 16-733, 2024.
[4]
J. Olofsson et al., "Array-Based Multiplex and High-Throughput Serology Assays," Methods in Molecular Biology, vol. 2628, s. 535-553, 2023.
[5]
M. Fuentes et al., "Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project," Journal of Proteome Research, vol. 22, no. 4, s. 1105-1115, 2023.
[6]
L. Thörnqvist et al., "Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy," Frontiers in Allergy, vol. 3, 2022.
[7]
M. Mikus et al., "Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy," Journal of Allergy and Clinical Immunology, vol. 147, no. 3, s. 1077-1086, 2021.
[8]
L. F. Al-Rabadi et al., "Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy," Journal of the American Society of Nephrology, vol. 32, no. 7, s. 1666-1681, 2021.
[9]
S. Hober et al., "Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay," Clinical & Translational Immunology (CTI), vol. 10, no. 7, 2021.
[10]
H. D. Bremer et al., "ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease," Scientific Reports, vol. 8, 2018.
[11]
A. Sierra-Sanchez et al., "Screening and Validation of Novel Biomarkers in Osteoarticular Pathologies by Comprehensive Combination of Protein Array Technologies," Journal of Proteome Research, vol. 16, no. 5, s. 1890-1899, 2017.
[12]
X. Zhou et al., "Thiol–ene–epoxy thermoset for low-temperature bonding to biofunctionalized microarray surfaces," Lab on a Chip, vol. 17, no. 21, s. 3672-3681, 2017.
[13]
U. Qundos et al., "Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients," PROTEOMICS - Clinical Applications, vol. 10, no. 6, s. 681-690, 2016.
[14]
B. Ayoglu et al., "Anoctamin 2 identified as an autoimmune target in multiple sclerosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 8, s. 2188-2193, 2016.
[15]
R. Sjöberg et al., "Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling," New Biotechnology, vol. 33, no. 5, s. 582-592, 2016.
[16]
R. Sjöberg, L. Hammarström och P. Nilsson, "Biosensor based protein profiling on reverse phase serum microarray," Journal of Proteomics and Bioinformatics, vol. 5, no. 8, s. 185-189, 2012.
[17]
J. Gantelius et al., "A Lateral Flow Protein Microarray for Rapid and Sensitive Antibody Assays," International Journal of Molecular Sciences, vol. 12, no. 11, s. 7748-7759, 2011.
[18]
K. Colwill et al., "A roadmap to generate renewable protein binders to the human proteome," Nature Methods, vol. 8, no. 7, s. 551-8, 2011.
[19]
R. Sjöberg et al., "Validation of affinity reagents using antigen microarrays," New Biotechnology, vol. 29, no. 5, s. 555-563, 2011.
[20]
M. Janzi et al., "Screening for C3 deficiency in newborns using microarrays.," PloS one, vol. 4, no. 4, s. e5321, 2009.
[21]
M. Janzi et al., "Selective IgA deficiency in early life : Association to infections and allergic diseases during childhood," Clinical Immunology, vol. 133, no. 1, s. 78-85, 2009.
[22]
R. Rimini et al., "Validation of serum protein profiles by a dual antibody array approach," , vol. 73, no. 2, s. 252-266, 2009.
Konferensbidrag
[23]
J. Gantelius et al., "A ten-minute high density lateral flow protein microarray assay," i 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011 : (MicroTAS 2011), 2011, s. 1176-1178.
Kapitel i böcker
[24]
E. Pin et al., "Array-based profiling of proteins and autoantibody repertoires in CSF," i Cerebrospinal Fluid (CSF) Proteomics, : Humana Press Inc., 2019, s. 303-318.
[25]
R. Sjöberg et al., "High-density antigen microarrays for the assessment of antibody selectivity and off-target binding," i Epitope Mapping Protocols, : Humana Press Inc., 2018, s. 231-238.
[26]
C. Hellström et al., "High-density serum/plasma reverse phase protein arrays," i Serum/Plasma Proteomics, : Humana Press, 2017, s. 229-238.
Icke refereegranskade
Artiklar
[27]
L. Lourido et al., "Identification of Circulating Autoantibodies Associated with ACPA Status in Early Rheumatoid Arthritis," Arthritis & Rheumatology, vol. 75, s. 3494-3495, 2023.
[28]
L. Lourido et al., "Identification and Validation of Four Circulating Autoantibodies Associated with the ACPA Status in Early Rheumatoid Arthritis," Arthritis & Rheumatology, vol. 73, s. 60-62, 2021.
[29]
L. Lourido et al., "PRESENCE OF FOUR SERUM AUTOANTIBODIES ASSOCIATES WITH THE ACPA STATUS IN EARLY RHEUMATOID ARTHRITIS," Annals of the Rheumatic Diseases, vol. 80, s. 425-426, 2021.
Avhandlingar
[30]
R. Sjöberg, "On Generation and Applications of High-Density Protein Microarrays," Doktorsavhandling Stockholm : KTH Royal Institute of Technology, TRITA-BIO-Report, 2015:12, 2015.
Övriga
[31]
R. Sjöberg et al., "Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling," (Manuskript).
[32]
D. Just et al., "Exploring the autoantibody repertoire in patients with obsessive compulsive disorder," (Manuskript).
[33]
A. Jernbom Falk et al., "Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19," (Manuskript).
[34]
B. Ayoglu et al., "The calcium-activated chloride channel anoctamine 2 as an autoimmune component of multiple sclerosis," (Manuskript).
Senaste synkning med DiVA:
2025-11-27 23:27:31 UTC